HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 94 filers reported holding HARPOON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -48.7% | 7,914 | -21.6% | 0.00% | – |
| Q4 2021 | $76,000 | -5.0% | 10,100 | 0.0% | 0.00% | – |
| Q3 2021 | $80,000 | -77.7% | 10,100 | -60.9% | 0.00% | – |
| Q2 2021 | $359,000 | -16.1% | 25,860 | +26.5% | 0.00% | -100.0% |
| Q1 2021 | $428,000 | +61.5% | 20,437 | +28.2% | 0.00% | – |
| Q4 2020 | $265,000 | -2.2% | 15,942 | 0.0% | 0.00% | – |
| Q3 2020 | $271,000 | +2.3% | 15,942 | 0.0% | 0.00% | – |
| Q2 2020 | $265,000 | +105.4% | 15,942 | +43.0% | 0.00% | – |
| Q1 2020 | $129,000 | -20.9% | 11,149 | +1.2% | 0.00% | – |
| Q4 2019 | $163,000 | +5.8% | 11,018 | -2.5% | 0.00% | – |
| Q3 2019 | $154,000 | +29.4% | 11,301 | +23.8% | 0.00% | – |
| Q2 2019 | $119,000 | +213.2% | 9,131 | +129.7% | 0.00% | – |
| Q1 2019 | $38,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |